Chronic Obstructive Airway Disease Collection
 1-20 of 24 Articles
ACP Journal Club |  15 April 2014
Review: Exercise programs after pulmonary rehabilitation preserve short-term exercise capacity in COPD
Yves Lacasse, MD, MSc, FRCPC
Ann Intern Med. 2014;160(8):JC4. doi:10.7326/0003-4819-160-8-201404150-02004
ACP Journal Club |  17 September 2013
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation
Diego J. Maselli, MD; Jay I. Peters, MD
Ann Intern Med. 2013;159(6):JC5. doi:10.7326/0003-4819-159-6-201309170-02005
ACP Journal Club |  18 June 2013
Review: Inhaled medications vary substantively in their effects on mortality in COPD
Shirin Shafazand, MD, MS, FCCP, FAASM
Ann Intern Med. 2013;158(12):JC2. doi:10.7326/0003-4819-158-12-201306180-02002
ACP Journal Club |  21 May 2013
Review: Nutritional supplementation has uncertain effects on patient-important outcomes in COPD
Christine McDonald, MBBS (Hons), FRACP, PhD, FCCP
Ann Intern Med. 2013;158(10):JC5. doi:10.7326/0003-4819-158-10-201305210-02005
ACP Journal Club |  16 April 2013
Review: Antibiotics reduce treatment failure in acute chronic obstructive pulmonary disease exacerbations
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2013;158(8):JC5. doi:10.7326/0003-4819-158-8-201304160-02005
ACP Journal Club |  19 March 2013
Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD
Sandra G. Adams, MD, MS; Jay I. Peters, MD
Ann Intern Med. 2013;158(6):JC3. doi:10.7326/0003-4819-158-6-201303190-02003
ACP Journal Club |  19 February 2013
Review: Corticosteroid plus LABA inhalers, vs LABAs alone, reduce morbidity in COPD
Shawn D. Aaron, MD
Ann Intern Med. 2013;158(4):JC9. doi:10.7326/0003-4819-158-4-201302190-02009
ACP Journal Club |  20 March 2012
Review: Long-term use of inhaled corticosteroids increases fracture risk in COPD
Ann Intern Med. 2012;156(6):JC3-7. doi:10.7326/0003-4819-156-6-201202210-02007
ACP Journal Club |  21 February 2012
Prior use of inhaled corticosteroids was associated with less mortality in elders with COPD and pneumonia
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2012;156(4):JC2-12. doi:10.7326/0003-4819-156-4-201202210-02012
ACP Journal Club |  17 January 2012
Azithromycin once daily for 1 year reduced acute COPD exacerbations
Jay Peters, MD; Antonio Anzueto, MD
Ann Intern Med. 2012;156(2):JC1-10. doi:10.7326/0003-4819-156-2-201201170-02010
ACP Journal Club |  18 October 2011
Review: Tiotropium mist inhaler increases mortality in chronic obstructive pulmonary disease
Brian J. Lipworth, MD
Ann Intern Med. 2011;155(8):JC4-6. doi:10.7326/0003-4819-155-8-201110180-02006
ACP Journal Club |  20 September 2011
Review: Oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD
Felix S.F. Ram, PhD, Clinical Pharmacologist
Ann Intern Med. 2011;155(6):JC3-2. doi:10.7326/0003-4819-155-6-201109200-02002
ACP Journal Club |  19 July 2011
Tiotropium reduced exacerbations more than salmeterol in moderate-to-very severe COPD
Peter Wark, BMed, FRACp, PhD
Ann Intern Med. 2011;155(2):JC1-3. doi:10.7326/0003-4819-155-2-201107190-02003
ACP Journal Club |  15 March 2011
A COPD disease management program reduced a composite of hospitalizations or emergency department visits
Kevin Park, MD; Richard A. Robbins, MD
Ann Intern Med. 2011;154(6):JC3-5. doi:10.7326/0003-4819-154-6-201103150-02005
ACP Journal Club |  20 July 2010
Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2010;153(2):JC1-3. doi:10.7326/0003-4819-153-2-201007200-02003
ACP Journal Club |  20 July 2010
Review: Tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease
Matthew B. Stanbrook, MD, PhD
Ann Intern Med. 2010;153(2):JC1-2. doi:10.7326/0003-4819-153-2-201007200-02002
ACP Journal Club |  20 April 2010
Male gender, diabetes, COPD, anemia, and creatinine clearance < 30 mL/min predicted hospitalization after heart failure diagnosis
Bertram Pitt, MD
Ann Intern Med. 2010;152(8):JC4-2. doi:10.7326/0003-4819-152-8-201004200-02002
ACP Journal Club |  16 March 2010
Review: Addition of inhaled corticosteroids to long-acting β2-agonists does not improve outcomes in stable COPD
Shawn D. Aaron, MD, MSc
Ann Intern Med. 2010;152(6):JC3-5. doi:10.7326/0003-4819-152-6-201003160-02005
ACP Journal Club |  19 January 2010
An updated BODE index and a simplified ADO index predicted 3-year mortality in COPD better than the original BODE index
Christine F. McDonald, MBBS, PhD
Ann Intern Med. 2010;152(2):JC1-12. doi:10.7326/0003-4819-152-2-201001190-02012
ACP Journal Club |  21 April 2009
Self-monitored, home-based pulmonary rehab was noninferior to outpatient, hospital-based rehab for COPD
Michael Greenstone, MD, FRCP
Ann Intern Med. 2009;150(8):JC4-7. doi:10.7326/0003-4819-150-8-200904210-02007

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.